Oleksi Petrenko

5.0k total citations · 2 hit papers
41 papers, 4.1k citations indexed

About

Oleksi Petrenko is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Oleksi Petrenko has authored 41 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Oncology and 13 papers in Immunology. Recurrent topics in Oleksi Petrenko's work include Cancer-related Molecular Pathways (13 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Oleksi Petrenko is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Oleksi Petrenko collaborates with scholars based in United States, Germany and France. Oleksi Petrenko's co-authors include Ute M. Moll, Motohiro Mihara, Susan Erster, Alexander Zaika, Thomas Chittenden, Petr Pančoška, Irene Ischenko, Alice Nemajerová, Günter Fingerle‐Rowson and Roger H. Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Oleksi Petrenko

41 papers receiving 4.0k citations

Hit Papers

p53 Has a Direct Apoptoge... 2003 2026 2010 2018 2003 2003 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oleksi Petrenko United States 24 2.6k 1.8k 819 639 355 41 4.1k
Kanaga Sabapathy Singapore 40 3.5k 1.3× 2.1k 1.2× 755 0.9× 1.2k 1.8× 366 1.0× 96 5.0k
Hayla K. Sluss United States 19 3.7k 1.4× 2.0k 1.1× 554 0.7× 744 1.2× 207 0.6× 25 4.8k
Carmé Caelles Spain 33 2.9k 1.1× 1.1k 0.6× 627 0.8× 571 0.9× 248 0.7× 56 4.2k
Olga Chernova United States 27 2.2k 0.8× 1.1k 0.6× 546 0.7× 565 0.9× 186 0.5× 42 3.7k
Paolo Salomoni United Kingdom 45 4.8k 1.8× 1.4k 0.8× 852 1.0× 776 1.2× 155 0.4× 104 6.5k
Stephen Baird Canada 25 3.2k 1.2× 621 0.3× 595 0.7× 522 0.8× 227 0.6× 48 4.1k
Reid P. Bissonnette United States 26 3.0k 1.2× 1.2k 0.6× 1.1k 1.3× 539 0.8× 106 0.3× 53 4.7k
Zhi-Min Yuan United States 35 3.0k 1.2× 1.6k 0.9× 364 0.4× 554 0.9× 299 0.8× 61 3.8k
Shigeru Sakiyama Japan 34 2.4k 0.9× 935 0.5× 634 0.8× 709 1.1× 329 0.9× 124 3.8k
Kiyotsugu Yoshida Japan 40 4.0k 1.5× 1.5k 0.8× 580 0.7× 859 1.3× 127 0.4× 108 5.4k

Countries citing papers authored by Oleksi Petrenko

Since Specialization
Citations

This map shows the geographic impact of Oleksi Petrenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleksi Petrenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleksi Petrenko more than expected).

Fields of papers citing papers by Oleksi Petrenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleksi Petrenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleksi Petrenko. The network helps show where Oleksi Petrenko may publish in the future.

Co-authorship network of co-authors of Oleksi Petrenko

This figure shows the co-authorship network connecting the top 25 collaborators of Oleksi Petrenko. A scholar is included among the top collaborators of Oleksi Petrenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleksi Petrenko. Oleksi Petrenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrenko, Oleksi, et al.. (2024). Intratumor heterogeneity in KRAS signaling shapes treatment resistance. iScience. 28(2). 111662–111662. 1 indexed citations
2.
Petrenko, Oleksi, Jinyu Li, Velasco Cimica, et al.. (2021). IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3. PLoS ONE. 16(3). e0247394–e0247394. 8 indexed citations
3.
Ischenko, Irene, Stephen D’Amico, Manisha Rao, et al.. (2021). KRAS drives immune evasion in a genetic model of pancreatic cancer. Nature Communications. 12(1). 1482–1482. 122 indexed citations
4.
Ischenko, Irene, et al.. (2014). Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells. Cell Death and Differentiation. 21(8). 1218–1228. 21 indexed citations
5.
Ischenko, Irene, Oleksi Petrenko, & Michael J. Hayman. (2014). Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proceedings of the National Academy of Sciences. 111(9). 3466–3471. 45 indexed citations
6.
Nemajerová, Alice, Gustavo Palacios, Norma J. Nowak, Seiichi Matsui, & Oleksi Petrenko. (2009). Targeted Deletion of p73 in Mice Reveals Its Role in T Cell Development and Lymphomagenesis. PLoS ONE. 4(11). e7784–e7784. 14 indexed citations
7.
Palacios, Gustavo, Flaminia Talos, Alice Nemajerová, Ute M. Moll, & Oleksi Petrenko. (2008). E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle. 7(12). 1776–1781. 7 indexed citations
8.
Nemajerová, Alice, Flaminia Talos, Ute M. Moll, & Oleksi Petrenko. (2008). Rb function is required for E1A-induced S-phase checkpoint activation. Cell Death and Differentiation. 15(9). 1440–1449. 14 indexed citations
9.
Fingerle‐Rowson, Günter & Oleksi Petrenko. (2007). MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Division. 2(1). 22–22. 28 indexed citations
10.
Nemajerová, Alice, et al.. (2007). Macrophage Migration Inhibitory Factor Coordinates DNA Damage Response with the Proteasomal Control of the Cell Cycle. Cell Cycle. 6(9). 1030–1034. 26 indexed citations
11.
Nemajerová, Alice, Patricio Mena, Günter Fingerle‐Rowson, Ute M. Moll, & Oleksi Petrenko. (2007). Impaired DNA damage checkpoint response in MIF‐deficient mice. The EMBO Journal. 26(4). 987–997. 51 indexed citations
12.
Talos, Flaminia, Alice Nemajerová, Elsa R. Flores, Oleksi Petrenko, & Ute M. Moll. (2007). p73 Suppresses Polyploidy and Aneuploidy in the Absence of Functional p53. Molecular Cell. 27(4). 647–659. 68 indexed citations
13.
Talos, Flaminia, Oleksi Petrenko, Patricio Mena, & Ute M. Moll. (2005). Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo. Cancer Research. 65(21). 9971–9981. 64 indexed citations
14.
Talos, Flaminia, et al.. (2005). MIF loss impairs Myc-induced lymphomagenesis. Cell Death and Differentiation. 12(10). 1319–1328. 30 indexed citations
15.
Mihara, Motohiro, Susan Erster, Alexander Zaika, et al.. (2003). p53 Has a Direct Apoptogenic Role at the Mitochondria. Molecular Cell. 11(3). 577–590. 1403 indexed citations breakdown →
16.
Ischenko, Irene, Oleksi Petrenko, Haihua Gu, & Michael J. Hayman. (2003). Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene. 22(41). 6311–6318. 18 indexed citations
17.
Petrenko, Oleksi, Günter Fingerle‐Rowson, Tina Peng, Robert A. Mitchell, & Christine N. Metz. (2003). Macrophage Migration Inhibitory Factor Deficiency Is Associated with Altered Cell Growth and Reduced Susceptibility to Ras-mediated Transformation. Journal of Biological Chemistry. 278(13). 11078–11085. 56 indexed citations
18.
Nikiforov, Mikhail A., Iulia Kotenko, Oleksi Petrenko, et al.. (2000). Complementation of Myc-dependent cell proliferation by cDNA expression library screening. Oncogene. 19(42). 4828–4831. 29 indexed citations
20.
Petrenko, Oleksi, Irene Ischenko, & Paula J. Enrietto. (1995). Isolation of a cDNA encoding a novel chicken chemokine homologous to mammalian macrophage inflammatory protein-1β. Gene. 160(2). 305–306. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026